Skip to main content
. 2013 Feb 4;27(3):163–168.

Figure 1.

Figure 1

Gd+ MS patients at baseline show lower PASAT scores (a) and iTBS-induced LTP (b) in comparison to Gd− patients, before starting treatment with IFN beta-1a.

* = p<0.05. Data points represent mean values; error bars represent standard error. PASAT=paced auditory serial addition test; iTBS=intermittent theta burst stimulation; LTP=long-term potentiation; GD=gadolinium enhancing lesions; IFN=interferon.